The United States spends more money on the care of back and neck pain than any other health condition. Despite this, the cost-effectiveness for many recommended treatments is unclear. Our primary ...
The incremental cost-effectiveness ratios for the target of less than 120 vs less than 130 mm Hg was $24,400 per quality-adjusted life-year with research-grade systolic blood pressure measurement in ...
Objective: The aim of this study was to evaluate the cost-effectiveness of toripalimab plus chemotherapy compared to chemotherapy alone as first-line therapy for extensive-stage small cell lung cancer ...
In the high-stakes landscape of cancer treatment where healthcare professionals rely on cost-effectiveness analyses to guide decisions adverse event costs may be throwing off the equation. A new ...
Randomized Phase III Trial of Ramucirumab Beyond Progression Plus Irinotecan in Patients With Ramucirumab-Refractory Advanced Gastric Cancer: RINDBeRG Trial We derived disease progression and therapy ...
Efanesoctocog alfa and standard-care factor VIII accrued 19.7 and 14.6 discounted lifetime quality-adjusted life years at costs of $22.1 and $11.2 million, respectively. HealthDay News — For US ...
Two popular medications used in the fight against obesity—semaglutide (Wegovy; Novo Nordisk) and tirzepatide (Zepbound; Eli Lilly)—are priced too high to be considered cost-effective by currently ...
Please provide your email address to receive an email when new articles are posted on . Semaglutide and tirzepatide were the least cost-effective of four obesity drugs examined in a microsimulation ...
Acronyms such as FFP (Financial Fair Play) and PSR (Profit and Sustainability Rules) have become part of the footballing furniture in recent years, but now a new set of terms is looming on the horizon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback